Literature DB >> 3957111

Effect of acetaminophen on human gastric mucosal injury caused by ibuprofen.

F L Lanza, G L Royer, R S Nelson, M F Rack, C E Seckman, J H Schwartz.   

Abstract

Acetaminophen has been proposed as an agent which protects the gastric mucosa against damage induced by aspirin and other non-steroidal anti-inflammatory agents. In order to evaluate this proposal further, 45 normal human volunteers were divided into three groups (n = 15); group one received ibuprofen 2400 mg daily (600 mg qid); group two received acetaminophen 3900 mg daily (975 mg qid) and group three received both drugs at the same dosages. There was no significant difference in the mucosal injury scores noted at endoscopy between the ibuprofen and the ibuprofen-acetaminophen group. The acetaminophen group had virtually no observed mucosal injury and this was statistically significant in comparison with the other groups (p less than 0.01). We conclude that contrary to previously reported studies using single doses of aspirin, acetaminophen failed to decrease the mucosal injury seen with ibuprofen when given for a period of seven days in combination with acetaminophen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957111      PMCID: PMC1433393          DOI: 10.1136/gut.27.4.440

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa.

Authors:  F Lanza; G Royer; R Nelson
Journal:  Gastrointest Endosc       Date:  1975-02       Impact factor: 9.427

2.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

3.  Gastric erosions induced by analgesic drug mixtures in the rat.

Authors:  A J Seegers; L P Jager; J Van Noordwijk
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

4.  Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.

Authors:  F L Lanza; G L Royer; R S Nelson
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

5.  Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy.

Authors:  G R Silvoso; K J Ivey; J H Butt; O O Lockard; S D Holt; C Sisk; W N Baskin; P A Mackercher; J Hewett
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

6.  Effects of ibuprofen, tolmetin and placebo on the gastric mucosa of aspirin-sensitive volunteers.

Authors:  F L Lanza; R S Nelson; G L Royer
Journal:  Am J Gastroenterol       Date:  1979-11       Impact factor: 10.864

7.  Effects of aspirin and an aspirin-acetaminophen combination on the gastric mucosa in normal subjects. A double-blind endoscopic study.

Authors:  D Y Graham; J L Smith
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

8.  Gastroscopic evaluation of anti-inflammatory agents.

Authors:  I Caruso; G Bianchi Porro
Journal:  Br Med J       Date:  1980-01-12

9.  The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study.

Authors:  F L Lanza; G L Royer; R S Nelson; T T Chen; C E Seckman; M F Rack
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

Review 10.  Ibuprofen.

Authors:  T G Kantor
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

View more
  3 in total

Review 1.  Pharmacological Management of Acute Endodontic Pain.

Authors:  Asma A Khan; Anibal Diogenes
Journal:  Drugs       Date:  2021-10-07       Impact factor: 9.546

2.  Esophageal ulcer induced by ibuprofen tablets.

Authors:  Xiao-Ling Xu; Hai-Hang Zhu; Jian Yin
Journal:  Chronic Dis Transl Med       Date:  2016-01-21

3.  Frequency and Types of Pathological Upper Gastrointestinal Endoscopy Findings in Clinically Healthy Individuals.

Authors:  Elisabeth Scheidl; Claus Benz; Peter Loeff; Volker Groneck; Andreas König; Alban Schulte-Fischedick; Hendrik Lück; Uwe Fuhr
Journal:  Drugs R D       Date:  2020-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.